Latest News - Boston Scientific
Top Corporates Hub
Boston Scientific
Boston Scientific (BSX) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
24.07.2026 13:15
Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
Have We Entered A Stealth Bear Market?
24.07.2026 01:00
For months I've had an uneasy feeling about the sustainability of this great bull run.
Boston Scientific (BSX) Enrolls First Patients In Global Faraflex AFib Trial
23.07.2026 07:13
Boston Scientific (NYSE:BSX) has enrolled the first patients in the global FARADIGM trial. The study evaluates the Faraflex pulsed field ablation device for the treatment of atrial fibrillation. This milestone marks the formal start of large scale clinical testing for the Faraflex system. Boston Scientific is a major player in cardiac rhythm and electrophysiology devices, and the FARADIGM trial adds another clinical program to that portfolio. Atrial fibrillation treatments have been an area...
Parnassus Growth Equity Fund Q2 2026 Portfolio Activity
17.07.2026 04:06
Twist Bioscience provides exposure to two powerful long-term trends in Health Care, AI-supported drug discovery and next-generation sequencing.
Why Did SPCX, IBM, BSX Drop To 52-Week Lows Today?
16.07.2026 03:06
SpaceX, IBM and Boston Scientific fell to 52-week lows on Wednesday as Wall Street concerns and profit-taking sent the stocks lower.
Boston Scientific (BSX) Faces WATCHMAN Slowdown But Analysts Still See Upside
15.07.2026 09:21
With an upside potential of 62.55%, Boston Scientific Corporation (NYSE:BSX) is among the 12 Strong Buy Stocks with High Upside According to Analysts. On July 8, Needham analyst Mike Matson lowered the firm’s price target on Boston Scientific Corporation (NYSE:BSX) to $57 from $77 while maintaining a Buy rating on the shares. The adjustment followed management commentary […]
Are Boston Scientific’s (BSX) Sterile-Packaging Recalls Reframing the Narrative on Quality and Regulatory Risk?
15.07.2026 01:12
Boston Scientific recently initiated several voluntary Class II recalls of its CRE and CRE Pro Wireguided endoscopy devices worldwide due to potential sterile breaches in packaging, affecting tens of thousands of units across multiple size ranges. The recalls underscore the operational and regulatory risks inherent in Boston Scientific’s expanding minimally invasive device portfolio, especially as it integrates recent acquisitions and scales global distribution. We’ll now examine how these...
1 Stock Under $50 to Keep an Eye On and 2 We Brush Off
13.07.2026 09:42
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
10.07.2026 13:30
The average brokerage recommendation (ABR) for Boston Scientific (BSX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Is Boston Scientific (BSX) Undervalued As Clinical Results Lift Optimism Despite Watchman Concerns?
07.07.2026 05:28
Boston Scientific stock moves after clinical results and index changes Boston Scientific (BSX) has come into focus after promising clinical results coincided with multiple index removals and fresh analyst commentary on its Watchman device franchise and utilization trends. Shares recently moved higher, supported by the clinical update and reports of insider buying, even as analysts highlighted slower Watchman growth and trimmed their expectations. At the same time, Boston Scientific was...
Is Boston Scientific (BSX) Still One of the Best Stocks to Invest In After Jefferies Slashed Its Target?
06.07.2026 19:41
Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to invest in according to Two Sigma Advisors with huge upside potential. On June 24, Jefferies analyst Matthew Taylor cut his price target on Boston Scientific Corporation (NYSE:BSX) to $67 from $100, while keeping a Buy rating on the stock. The analyst stated that a […]
Boston Scientific (BSX) Stock Could Be A Bargain After A 57% Slump
06.07.2026 17:07
Boston Scientific stock has fallen 56.5% over the past year, yet the valuation checks still lean toward the shares looking cheap relative to fundamentals and recent news has put a fresh spotlight on whether that gap is justified. The 56.5% one year share price decline raises the question of whether Boston Scientific is being priced for a much weaker outlook than its long term potential would suggest. On one side, the US$1.5b investment in MiRus and option to acquire its TAVR business may...
Fiserv And Lululemon Lessons Revisited: 5 Popular Stocks With Quant Sell Ratings
06.07.2026 13:30
Fiserv and lululemon crashes followed Quant Sell ratings. Click here to see 5 popular stocks that currently warrant investor caution.
Boston Scientific Corp (NYSE:BSX) Offers Strong Value with High Profitability and Solid Growth
06.07.2026 08:40
Boston Scientific (BSX) offers a compelling value opportunity with a low P/E of 14.56, strong profitability, and solid growth, identified through ChartMill's "Decent Value" screen as a quality stock trading at a discount.
Boston Scientific’s Quarterly Earnings Preview: What You Need to Know
02.07.2026 07:11
Boston Scientific is gearing up for earnings day, weighing a rocky stock run against Wall Street's stubbornly optimistic outlook.
Boston Scientific (BSX) Invests $1.5B in MiRus for Equity Stake and TAVR Acquisition Option
30.06.2026 11:14
Boston Scientific Corporation (NYSE:BSX) is one of the oversold tech stocks to buy now. On May 18, Boston Scientific invested $1.5 billion for a 34% equity stake in MiRus LLC, a company specializing in advanced biomaterials and medical implants. The deal includes an exclusive option for Boston Scientific to acquire MiRus’s proprietary TAVR system, which […]
Boston Scientific Corp (NYSE:BSX) Meets All Caviar Cruise Quality Criteria for Long-Term Investors
29.06.2026 10:00
Boston Scientific (BSX) passes the Caviar Cruise quality screen with 27% ROIC, 34.7% EBIT growth, and strong cash flow. A durable long-term investment candidate.
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
26.06.2026 14:48
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 9.5% over the past six months while the S&P 500 was up 6.2%.
TD Cowen Maintains a Buy Rating on Boston Scientific (BSX)
25.06.2026 11:58
Boston Scientific Corporation (NYSE:BSX) is one of the Stocks Expected to Bounce Back According to Analysts. The stock has fallen more than 52% year-to-date, but the Street expects more than 65% upside from the current level. Recently, on June 16, TD Cowen analyst Josh Jennings maintained his Buy rating on Boston Scientific Corporation (NYSE:BSX) with […]
Piper Sandler Maintains Overweight Rating for Boston Scientific (BSX)
23.06.2026 15:06
Boston Scientific Corp. (NYSE:BSX) is one of the 10 oversold stocks offering high upside. On June 12, Matt O’Brien from Piper Sandler reduced the target price on Boston Scientific Corporation (NYSE:BSX) from $90 to $65, resulting in an adjusted upside potential of close to 45% at the current level. The analyst retained an Overweight rating […]